Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014

Conference Call and Webcast to Follow

FOSTER CITY, Calif.--()--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2014 financial results will be released on Tuesday, April 22, at 4:05 p.m. Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the first quarter 2014 and provide a general business update. The conference call will be accessible via the internet from the company’s website.

To access the webcast link, log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 1-844-795-1482 (U.S.) or 1-931-229-4695 (international) and dial the conference call ID 17493454 to access the call. Telephone replay will be available approximately two hours after the call through 11:59 p.m. Eastern Time, April 25, 2014. To access the replay, please call 1-855-859-2056 (U.S.) or 1-404-537-3406 (international) and dial the conference call ID 17493454. The webcast will be archived on www.gilead.com for one year.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contacts

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations

Sharing

Contacts

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations